Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Unknown 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Breast 1

Conditions

Breast Neoplasms 3Weight Loss 2Psoriasis 1Osteoarthritis 1Neoplasms 1Muscular Atrophy 1Muscle Weakness 1Motor Activity 1Colitis, Ulcerative 1Cancer Cachexia 1Autoimmune Diseases 1Arthritis, Rheumatoid 1

Interventions

Exercise 7Caloric Restriction 5Diet 4Cognitive Behavioral Therapy 3Octreotide 2Metformin 2Eicosapentaenoic Acid 2Diet Therapy 2Weight Reduction Programs 1TOPS 1Sugars 1Standard of Care 1Sampling Studies 1Resistance Training 1Psychology, Positive 1Population Groups 1Palliative Care 1Nutritional Status 1Nutrition Assessment 1Methods 1Melatonin 1Inositol 1Ibuprofen 1Hypoxanthine Phosphoribosyltransferase 1Growth Differentiation Factor 15 1Fatty Acids, Omega-3 1Endoscopy, Digestive System 1Docosahexaenoic Acids 1Diet, Vegetarian 1Diet, Vegan 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase NA × Weight Loss × Eicosapentaenoic Acid × Clear all
NCT02101970 2022-01-24

Weight Loss Plus Omega-3 Fatty Acids or Placebo in High Risk Women

University of Kansas Medical Center

Phase NA Completed
46 enrolled
Breast

Breast Neoplasms, Weight Loss

NCT03151291 2018-10-16

Effects of WB-EMS and Specific Dietary Supplements on Cancer Patients

University of Erlangen-Nürnberg Medical School

Phase NA Unknown
200 enrolled

Motor Activity, Muscular Atrophy, Neoplasms, Weight Loss, Muscle Weakness

Data powered by HemOnc (CC BY 4.0) Colophon âš¡